D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
C3.ai
AI
$1.37B
| $4.16M | ﹤0.01% |
371,640
+334,829
| +910% | +$4.19M |
|
2127
Five Below
FIVE
$11.5B
| $4.16M | ﹤0.01% |
23,495
-336
| -1% | -$52.8K |
|
2128
Allogene Therapeutics
ALLO
$604M
| $4.15M | ﹤0.01% |
660,187
+220,492
| +50% | +$2.04M |
|
2129
Verra Mobility
VRRM
$636M
| $4.15M | ﹤0.01% |
299,788
+183,771
| +158% | +$2.79M |
|
2130
Blue Owl Capital
OBDC
$5.42B
| $4.14M | ﹤0.01% |
358,060
+254,146
| +245% | +$3.05M |
|
2131
Pliant Therapeutics
PLRX
$66.9M
| $4.13M | ﹤0.01% |
213,801
-1,514
| -0.7% | -$31.7K |
|
2132
MINISO
MNSO
$3.72B
| $4.13M | ﹤0.01% |
+384,982
| New | +$3.22M |
|
2133
CALL
ScottsMiracle-Gro
SMG
$4.06B
| $4.13M | ﹤0.01% |
+85,000
| New | +$4.26M |
|
|
BRD
2134
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $4.13M | ﹤0.01% |
405,200
| – | – |
|
2135
PUT
Wingstop
WING
$3.74B
| $4.13M | ﹤0.01% |
30,000
| – | – |
|
|
ASBP
2136
Aspire Biopharma
ASBP
$9.03M
| $4.13M | ﹤0.01% |
333
| – | – |
|
|
EBAC
2137
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $4.13M | ﹤0.01% |
408,574
+150,000
| +58% | +$1.5M |
|
2138
Federated Hermes
FHI
$4.5B
| $4.13M | ﹤0.01% |
+113,622
| New | +$3.99M |
|
2139
CALL
Northern Oil and Gas
NOG
$2.21B
| $4.12M | ﹤0.01% |
+133,800
| New | +$4.5M |
|
2140
PUT
Match Group
MTCH
$9.05B
| $4.12M | ﹤0.01% |
99,200
-56,800
| -36% | -$2.57M |
|
2141
Zumiez
ZUMZ
$328M
| $4.12M | ﹤0.01% |
189,290
+99,269
| +110% | +$2.2M |
|
|
ANSS
2142
PUT
DELISTED
Ansys
ANSS
| $4.11M | ﹤0.01% |
17,000
+500
| +3% | +$116K |
|
2143
CALL
Super Micro Computer
SMCI
$19.3B
| $4.11M | ﹤0.01% |
+500,000
| New | +$3.81M |
|
|
PNST
2144
DELISTED
Pinstripes Holdings, Inc.
PNST
| $4.08M | ﹤0.01% |
400,000
| – | – |
|
2145
Syndax Pharmaceuticals
SNDX
$1.82B
| $4.08M | ﹤0.01% |
160,435
+32,407
| +25% | +$756K |
|
2146
PUT
Signet Jewelers
SIG
$3.72B
| $4.08M | ﹤0.01% |
60,000
+29,500
| +97% | +$1.88M |
|
|
CFFS
2147
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $4.08M | ﹤0.01% |
400,000
| – | – |
|
2148
Target Hospitality
TH
$1.6B
| $4.08M | ﹤0.01% |
269,318
+164,769
| +158% | +$2.22M |
|
2149
Pool Corp
POOL
$6.73B
| $4.08M | ﹤0.01% |
13,480
-1,911
| -12% | -$605K |
|
2150
GoodRx Holdings
GDRX
$1.03B
| $4.07M | ﹤0.01% |
874,424
-76,919
| -8% | -$379K |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.